Should Pharma Focus on New Chemical Entities to Avoid Patent Challenge?




Pharmaceuticals & Biotechnology | Pharma & Biotech Resources show

Summary: As part of the new Pharma Leaders Today series, Philip C. Strassburger, V.P., Intellectual Property Counsel at Purdue Pharma, spoke to Andrea Charles from Pharma IQ, about what trends he is currently seeing in pharmaceutical and biotech patents and overcoming